ArticleIn vivo (Athens, Greece)

Alternate-day Capecitabine Plus Trastuzumab for Frail HER2-positive Gastric Cancer: A Pilot Case Series.

Naoki Odaira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.